Soufflé discovers and develops cell-specific ligands to deliver siRNA-based medicines that are rationally designed and transferred across the cell membrane to their target.
Biotech
Healthcare
AI
Details
- Founded
- 2022
- Partnered
- 2024
- Status
- Active
Soufflé discovers and develops cell-specific ligands to deliver siRNA-based medicines that are rationally designed and transferred across the cell membrane to their target.
The fastest Centaur in enterprise software history: how they got there and how they doubled to $200M ARR in less than six months.
AI has widened the gap between a great leader and an average one. Five functional trends are evolving the C-suite—and here’s how CEOs can find the executives best equipped for what's next.
Enterprise decision-making is scaling more accurately and efficiently with AI-simulated populations.
